Hydrochloric Acid → HCID 57656808, 화합물

HRID 2371183노트

반응식

HRID 2371183 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([NH:9][C:10]([N:12]2[CH2:17][CH2:16][N:15]([CH2:18][CH:19]3[CH2:24][N:23]([CH2:25][CH3:26])[CH2:22][CH2:21][N:20]3C(OCC3C=CC=CC=3)=O)[CH2:14][CH2:13]2)=[O:11])[CH:5]=[CH:6][C:7]=1[Cl:8].Cl>O1CCOCC1>[Cl:1][C:2]1[CH:3]=[C:4]([NH:9][C:10]([N:12]2[CH2:17][CH2:16][N:15]([CH2:18][CH:19]3[CH2:24][N:23]([CH2:25][CH3:26])[CH2:22][CH2:21][NH:20]3)[CH2:14][CH2:13]2)=[O:11])[CH:5]=[CH:6][C:7]=1[Cl:8]

참가 물질

4

실험 절차

To benzyl 2-[(4-{[(3,4-dichlorophenyl)amino]carbonyl}piperazin-1-yl)methyl]-4-ethylpiperazine-1-carboxylate (20 mg) was added 4M HCl in dioxane (1 ml). The solvent was evaporated, 1-methyl-2-pyrrolidinone (1 ml), zinc bromide (10 mg) and 10% palladium on carbon (50 mg) added and the mixture stirred under hydrogen at RT for 72 hours. Evaporation to dryness and purification on a 10 g SCX2 column, eluting sequentially with ethyl acetate, MeOH and 1% ammonia/MeOH gave the title compound (9 mg, 60%) by precipitation from CH2Cl2 with isohexane.

후처리

  1. customThe solvent was evaporated
  2. addition1-methyl-2-pyrrolidinone (1 ml), zinc bromide (10 mg) and 10% palladium on carbon (50 mg) added
  3. customEvaporation
  4. customto dryness and purification on a 10 g SCX2 column
  5. washeluting sequentially with ethyl acetate, MeOH and 1% ammonia/MeOH

출처 및 근거

ORD 기록
ord-4e3f6f2cef444747ad9e662f10eb28a6
출처 데이터셋
uspto-grants-2014_04
특허 번호
US08710224B2

반응 노트

불러오는 중…